Analysis of the 100% Apportionment Rate for Small Business Alternative Simplified Credit under Delaware R&D Tax Law (30 Del. Code § 2070)

I. Executive Summary and Statutory Context

1.1. Simple Definition of the 100% Small Business ASC Rate

The 100% Apportionment Rate for small businesses using the Alternative Simplified Credit (ASC) method doubles the standard Delaware R&D tax incentive, allowing qualifying companies to claim the full amount of the calculated Delaware-apportioned federal ASC.

This enhanced rate is available to companies with average annual gross receipts under the $\$20,000,000$ threshold and provides a fully refundable cash benefit to bolster early-stage R&D investment within the State.1

1.2. The Legislative Mandate and Policy Drivers (30 Del. Code § 2070)

The statutory foundation for the Delaware Research and Development (R&D) Tax Credit is contained within Title 30, Chapter 20, Subchapter VIII, Section 2070 of the Delaware Code.3 This legislation establishes the framework for an annual, elective credit available to taxpayers incurring Qualified Research Expenses (QREs) within the state. The statute outlines two primary methods for calculating the credit, providing taxpayers with flexibility based on their financial history and research expenditure patterns.

A critical enhancement to this incentive structure was introduced via legislative amendment (HB 318) in 2014, specifically targeting small businesses. This amendment expanded the R&D tax credit to provide greater benefit to small business entities, explicitly stipulating that if a company’s average annual gross receipts do not exceed $\$20,000,000$, the state R&D tax credit shall be equal to $100\%$ of the amount of the corresponding federal credit attributable to Delaware research activity.4 This targeted enhancement reflects a clear legislative intent to support high-growth, innovation-focused startups and smaller firms that often operate with minimal or zero corporate income tax liability in their early stages. The fact that the entire credit is fully refundable—meaning any amount exceeding the corporation’s tax liability is issued as a direct cash refund—magnifies the impact of the $100\%$ rate, transforming the credit from merely a liability reduction tool into a substantial, liquid cash flow subsidy for R&D investment.1 The credit’s refundability ensures that the state’s incentive is realized immediately, providing immediate liquidity regardless of profitability.1

1.3. Dual Calculation Paths and the ASC Method Preference

Delaware taxpayers must make an annual election between two calculation methods, independent of their federal election 3:

1. Method A (Traditional): Under the general rule, the credit is $10\%$ of the excess of the Delaware QREs over the Delaware base amount. For a qualifying small business, the statute substitutes this rate with $20\%$.1
2. Method B (Alternative Simplified Credit – ASC): Under the general rule, the credit is $50\%$ of Delaware’s apportioned share of the federal R&D tax credit calculated using the Alternative Simplified Credit (ASC) method under Internal Revenue Code (IRC) $\S 41(c)(5)$. For a qualifying small business, the statute substitutes the $50\%$ multiplier with $100\%$.3

The $100\%$ multiplier available under Method B, anchored to the ASC calculation, provides the primary strategic lever for small R&D firms in Delaware. The ASC method is inherently simpler for younger companies compared to the traditional method, as it requires calculation based on a three-year average of QREs rather than a complex four-year average of gross receipts and QREs to establish a fixed-base percentage.1 By doubling the multiplier for this more accessible methodology, the Delaware legislature ensures the largest possible cash benefit reaches the newest, smallest entities, maximizing the incentive for those firms that need capital the most.

II. Defining the Qualified Small Business and Apportionment Foundation

2.1. The Statutory Definition and Federal Nexus

The enhanced $100\%$ multiplier is strictly reserved for taxpayers meeting the statutory definition of a “small business” as defined in 30 Del. Code $\S 2070(a)(2)$. This definition is quantitative and specific: a small business means any taxpayer with average annual gross receipts (AAGR) not in excess of the applicable threshold of $\$20,000,000$.3

Crucially, the methodology for determining this AAGR must adhere precisely to the rules set forth in federal law under IRC $\S 41(c)(1)(B)$.3 This direct linkage to the federal tax code ensures consistent application of the threshold, preventing divergent state-level interpretations of gross receipts. Furthermore, the statute explicitly requires taxpayers making use of the alternative calculation (Method B or the enhanced Method A) to conform to this small business definition, regardless of the method they chose for their federal R&D credit determination.3 This conformity rule ensures that the state benefit is accurately targeted toward the intended recipients.

2.2. Deconstruction of the R&D Apportionment Mechanism

Understanding the function of the “apportionment rate” in this context requires distinguishing the mechanism used for the R&D credit from the general corporate income tax (CIT) apportionment.

Delaware’s general corporate income tax liability for multi-state firms is determined by apportioning taxable income to the state. Since January 1, 2020, Delaware has shifted entirely to a single sales factor (SSF) apportionment method for CIT, meaning only the ratio of Delaware gross receipts to total gross receipts is used for general corporate income tax purposes.4

However, the apportionment for the R&D tax credit is entirely separate and based solely on the location of research activity (Qualified Research Expenses). For the R&D credit, the apportionment factor is calculated as the ratio of Delaware QREs to total United States QREs.3

The choice to base the credit apportionment on QREs rather than the Single Sales Factor demonstrates Delaware’s intent to reward physical investment location. If the credit were apportioned using the SSF, a startup that conducts $100\%$ of its research in Delaware but sells its products nationally might receive a very low credit percentage, severely diminishing the incentive. By using the QRE ratio, Delaware guarantees that the R&D incentive is maximized for companies that physically locate their research infrastructure within the state, irrespective of their market presence. This ensures that the incentive directly drives the desired behavior: the creation of in-state research jobs and infrastructure.

2.3. Legal Interpretation of the “Apportioned Share”

The calculation pathway for the 100% ASC credit legally interprets the “Delaware’s apportioned share of taxpayer’s federal research and development tax credit” as the initial credit base. The specific statutory language defines this base as:

$$\text{Delaware’s apportioned share} = \text{Federal ASC} \times \frac{\text{Delaware QREs}}{\text{Total QREs}}$$

This calculation establishes the dollar value of the federal ASC that is mathematically attributable to the research activities conducted in Delaware.3 The resulting value is the apportioned base.

The final step is applying the statutory multiplier. For standard taxpayers, the final credit is $50\%$ of this base. For qualified small businesses, 30 Del. Code $\S 2070(a)(2)$ mandates the substitution of “$100\%$” for “$50\%$.” Therefore, the $100\%$ rate is a multiplier applied to an already geographically apportioned base, confirming that the full value of the localized federal credit benefit is transferred directly to the small business taxpayer.

III. Detailed Mechanics of the 100% ASC Calculation (Method B)

3.1. Prerequisite: Federal ASC Calculation (IRC § 41(c)(5))

Before calculating the Delaware credit, the taxpayer must first finalize the computation of the federal Alternative Simplified Credit (ASC) amount. This computation is carried out on federal Form 6765, following the rules established under IRC $\S 41(c)(5)$.

The federal ASC is calculated as $14\%$ of the current year’s QREs that exceed $50\%$ of the average QREs incurred during the three immediately preceding taxable years.1 If the taxpayer has no prior QREs (as is often the case for a new startup), the base is zero. This calculation must adhere strictly to federal definitions and methodology, establishing the maximum potential credit before state-specific apportionment.3

3.2. Calculation Steps for the 100% Delaware Credit

The calculation of the Delaware R&D Tax Credit under the 100% Small Business ASC method (Method B) follows three distinct steps, utilizing the Federal ASC amount as the starting point:

1. Determine the Apportionment Ratio (QRE Ratio): The taxpayer identifies the ratio of Delaware QREs (qualified research expenses physically incurred within Delaware) to the total QREs incurred across all jurisdictions within the United States.
2. Calculate the Delaware Apportioned Credit Base: The Federal ASC amount (from Form 6765) is multiplied by the Apportionment Ratio calculated in Step 1. This step isolates the portion of the total federal credit that corresponds to research activity performed in Delaware.3
3. Apply the Enhanced Multiplier: The Delaware Apportioned Credit Base is then multiplied by $100\%$ to yield the final Delaware R&D Tax Credit amount.

3.3. Annual Election and Independence

A defining feature of the Delaware R&D credit regime is the requirement that the taxpayer must make an annual election between the two methods (Method A or Method B).3 This election is explicitly independent of the method chosen by the taxpayer for determining their federal R&D credit.3

The independence of the state election necessitates sophisticated, year-end modeling to determine the optimal method prior to filing the Delaware return. For a mature small business with consistent QREs and historical gross receipts data, Method A (offering $20\%$ of excess QREs over a base amount) may yield a higher credit if the base calculation is favorable. However, for volatile or newly established startups, Method B (the $100\%$ ASC method) often provides the most advantageous outcome, capitalizing maximally on the $100\%$ multiplier with a less complex calculation.1 The ability to choose the most beneficial method annually provides crucial flexibility for strategic tax planning.

IV. Division of Revenue Guidance and Compliance Procedures

4.1. Compliance Documentation and Filing (Form 2071AC and Form 700)

To claim the credit, qualified taxpayers must follow specific administrative procedures set by the Delaware Division of Revenue (DOR). The core documentation requirement is the submission of the Application and Computation Schedule for Claiming Delaware Research and Development Tax Credits, identified generally as Form 2071AC.9

The application, Form 2071AC, must be submitted to the Division of Revenue on or by September 15 following the end of the taxable year during which the qualified R&D expenses were made.2 Critical attachments include a copy of the taxpayer’s Federal Form 6765. If the corporate applicant is part of a consolidated group for federal tax purposes, a proforma Form 6765 specific to the corporate applicant must be provided.9

Taxpayers must first receive approval from the Delaware Division of Revenue for the credit amount. Once approved, the final credit amount from Form 2071AC is transferred to the appropriate line on Delaware Form 700, the Corporate Income Tax Return. Both Form 700 and the approved Form 2071AC must be attached to the annual income tax return.9 The Division of Revenue provides assistance and can be contacted via email at DOR_CorpTax@Delaware.gov.9

4.2. Reconciliation of Statutory Law vs. Administrative Forms

A significant compliance issue arises from potential administrative lag in updating official DOR forms and instructions. The statutory text of 30 Del. Code $\S 2070(a)(2)$ clearly mandates the $100\%$ multiplier for small businesses utilizing the Alternative Simplified Credit (ASC) method (IRC $\S 41(c)(5)$).3

However, historical and some current versions of the Division of Revenue forms, such as Form 2071AC, have often referred to Method B as the Alternative Incremental Credit (AIC, calculated under IRC $\S 41(c)(4)$) and explicitly contain calculation steps requiring multiplication by $50\%$ on the final line for Method B.9 For example, the instruction for Line 6 of Method B has historically stated: “This is your Delaware Research & Development Credit. Multiply Line 5 by 50%”.9

In the case of a conflict between the specific mandate of the Delaware Code and the instructions provided on an administrative form, the statutory law prevails. Therefore, a tax professional preparing the return for a qualified small business electing Method B must apply the $100\%$ multiplier as directed by 30 Del. Code $\S 2070(a)(2)$, documenting the adjustment and citing the statutory authority, even if the form instruction suggests a $50\%$ rate. Relying solely on the administrative instructions without referencing the Code would result in an immediate and avoidable $50\%$ reduction of the intended state benefit.

4.3. Full Refundability and Cash Flow Implications

The Delaware R&D Tax Credit is fully refundable, a feature that provides significant financial benefit, particularly to small, non-profitable, R&D-intensive companies.1 The approved credit amount is first applied against the taxpayer’s qualified tax liability for the taxable year.3 Any unused credit amount exceeding the tax liability is paid to the taxpayer as a direct tax refund.2

Furthermore, effective January 1, 2017, the prior statutory cap of $\$5,000,000$ on the total annual tax credits issued by the State of Delaware was removed.9 The combination of full refundability and the removal of the aggregate annual cap ensures that qualifying small businesses can rely on the maximum statutory benefit ($100\%$ of the apportioned federal ASC) as a guaranteed and substantial source of working capital for continued research operations.

V. Financial Modeling and Numerical Example

To fully illustrate the mechanism and the financial impact of the $100\%$ multiplier, a detailed numerical example of a qualified small business utilizing Method B (ASC) is presented.

5.1. Parameters for Hypothetical Small Business R&D Credit Calculation

Consider “Innovate DE Corp,” a multi-state technology firm that qualifies as a small business for the current tax year. The firm’s research activities are predominantly centralized in Delaware.

Table Title: Parameters for Hypothetical Small Business R&D Credit Calculation

5.2. Step-by-Step Calculation of Delaware R&D Tax Credit (Method B – ASC)

The following calculation demonstrates the application of the $100\%$ multiplier and compares the result to the standard $50\%$ rate, highlighting the value of the small business status.

Table Title: Calculation and Comparison of Delaware R&D Tax Credit (Method B – ASC)

5.3. Analysis of the Strategic Advantage

The example above confirms that the $100\%$ multiplier provides a compounding financial advantage. By locating $80\%$ of its QREs in Delaware, Innovate DE Corp generates a credit base of $\$360,000$. The $100\%$ small business rate allows the firm to realize the entirety of that apportioned base as a state credit, resulting in a $\$360,000$ benefit. A standard taxpayer with the same expenditures would only receive $\$180,000$, demonstrating a significant, non-dilutive capital injection of $\$180,000$ solely due to the small business statute.1

Moreover, the structure of Method B (ASC) provides predictability. Unlike Method A, which relies on a multi-year base percentage tied to gross receipts, the ASC method is anchored to a defined federal rate applied to current QREs over a three-year average base.1 For a startup experiencing volatile gross receipts or rapid increases in QREs, utilizing the $100\%$ ASC multiplier provides the simplest and often maximum benefit, as the potential complexity and variability associated with calculating a traditional fixed-base percentage are circumvented.

VI. Conclusion and Strategic Recommendations

6.1. Best Practices and Audit Defense

Taxpayers electing the 100% Small Business ASC method must implement rigorous compliance measures to sustain their claims under audit. Given the potential administrative ambiguity arising from outdated form instructions, strict adherence to the law is paramount.

Tax professionals must base the $100\%$ multiplier claim explicitly on the clear text of 30 Del. Code $\S 2070(a)(2)$, which mandates the substitution of “$100\%$” for “$50\%$” for small businesses.3 This statutory priority must be maintained over any conflicting or confusing administrative guidance, such as the $50\%$ multiplier referenced on historical iterations of Form 2071AC.9

Comprehensive documentation is mandatory, including detailed records proving that the QREs were incurred while conducting qualified research physically within Delaware, thereby justifying the QRE apportionment ratio used.2 Due to the specific nature of the multiplier, it is highly recommended that tax professionals use a cover letter or supporting schedule with the Form 700 filing to clearly articulate the basis for the $100\%$ multiplier under $\S 2070(a)(2)$. This proactive communication ensures the Division of Revenue reviewer immediately understands the legal foundation for the calculation, minimizing potential correspondence or audit inquiries related to the apparent disparity with standard form instructions.

6.2. Strategic Planning for Growth and Credit Erosion

The $\$20$ million AAGR threshold represents a soft cliff edge in tax planning. Once a company exceeds this limit, it immediately loses the $100\%$ multiplier, resulting in an instantaneous $50\%$ reduction in the state R&D tax credit realized via the ASC method. Management must, therefore, regularly model their AAGR trajectory to forecast the year they are likely to cross this threshold.

As a company approaches the $\$20,000,000$ threshold, strategic tax planning is required to mitigate the inevitable erosion of the credit benefit. Since the R&D credit apportionment is tied specifically to the location of QREs, taxpayers should prioritize maximizing Delaware QREs as they grow, ensuring the apportioned base remains as large as possible. Even after losing the $100\%$ multiplier, a high QRE concentration in Delaware will still yield a significantly higher credit (albeit at $50\%$ of the apportioned base) compared to a business that distributes its R&D activity across multiple states.

Finally, corporations engaged in multi-state operations must ensure their internal tax processes accurately and distinctly segregate the two apportionment methodologies used in Delaware: the Single Sales Factor (SSF) used for computing general corporate taxable income (Form 700) and the QRE Ratio used exclusively for calculating the R&D credit base (Form 2071AC). Maintaining clear segregation prevents potential factor mismatch issues that commonly trigger state audit scrutiny. The $100\%$ ASC rate is a powerful tool designed for nascent firms, but its full advantage can only be retained and realized through diligent, technically sound, and statutory-based compliance.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/